PEOPLE - Oxis International makes appointment:
This article was originally published in Clinica
Executive Summary
Portland, Oregon-based oxidative stress diagnostics firm Oxis International has named Dr Gosse Bruinsma as chairman of the board of directors, following the retirement of current chairman, CEO and president, Ray Rogers. Dr Bruinsma, currently a member of the board, will also assume the role of acting CEO until a permanent appointment is made. Dr Bruinsma is president and COO of Anonyx, the majority shareholder in Oxis.
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.